scispace - formally typeset
R

Roberto Pellicciari

Researcher at University of Perugia

Publications -  358
Citations -  15591

Roberto Pellicciari is an academic researcher from University of Perugia. The author has contributed to research in topics: Metabotropic glutamate receptor & Bile acid. The author has an hindex of 55, co-authored 352 publications receiving 14034 citations. Previous affiliations of Roberto Pellicciari include École Polytechnique Fédérale de Lausanne & G. D. Searle & Company.

Papers
More filters
Journal ArticleDOI

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

TL;DR: It is shown here that TGR5 signaling induces intestinal glucagon-like peptide-1 (GLP-1) release, leading to improved liver and pancreatic function and enhanced glucose tolerance in obese mice, and suggested that pharmacological targeting of T GR5 may constitute a promising incretin-based strategy for the treatment of diabesity and associated metabolic disorders.
Journal ArticleDOI

Targeting bile-acid signalling for metabolic diseases

TL;DR: How the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis are reviewed.
Journal ArticleDOI

Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

TL;DR: Pharmacological agents targeting specific KP enzymes can be used to normalize KP defects, show remarkable efficacy in animal models of central nervous system disorders, and offer novel therapeutic opportunities.
Journal ArticleDOI

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.

TL;DR: It is demonstrated that activation of TGR5 in macrophages by 6α-ethyl-23(S)-methylcholic acid (6-EMCA, INT-777), a semisynthetic BA, inhibits proinflammatory cytokine production, an effect mediated by T GR5-induced cAMP signaling and subsequent NF-κB inhibition.